Stay updated on RAD vs VRD in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the RAD vs VRD in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the RAD vs VRD in Newly Diagnosed Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.3 was added to the page history and the HHS Vulnerability Disclosure link was removed from the footer. The changes pertain to site metadata and navigation rather than study data or content.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.2 was added to the record history, replacing the previous v3.3.1 entry; no study data or core page content were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe changes show an addition of Revision: v3.3.1 and a deletion of Revision: v3.2.0 in the Record History, indicating a minor software/record-keeping update rather than a modification to trial data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the government funding/operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check51 days agoChange DetectedThe version history shows updates to recruitment status and study status across multiple versions, reflecting changes in enrollment and overall trial status.SummaryDifference0.1%

- Check80 days agoChange DetectedUpgrade to v3.2.0 and include a government funding/operating-status notice; removes the old v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to RAD vs VRD in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAD vs VRD in Newly Diagnosed Multiple Myeloma Clinical Trial page.